semaglutide fda approval New Weight Loss Medication Wegovy™ Approved by the Live Updates on Semaglutide's Current
Description
doi: 10.2337/dc15-0779
The tolerability story is also good: nausea rates of 25% are lower than Semaglutides, which aligns with the theory that GIP co-activation improves GI tolerance
Medical writing support, under the direction of the authors, was provided by Eric Comeau, Ph.D., of CMC Connect, McCann Health Medical Communications and was funded by Pfizer Inc., New York, NY, USA, in accordance with Good Publication Practice (GPP3) guidelines (Ann Intern Med 2015;163:461464).
Viszont nem gyzzk hangslyozni, hogy a GLP-1 kr pl gygyszeres megoldsok ugyan lteznek, azonban nem egyenlk a gygyszerekkel
